Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CCCC

C4 Therapeutics, Inc.

CIK 0001662579 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$4.00
↓ 0.03 (-0.74%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$492.10M
P/E Ratio
-4.85
EPS
-1.27
Dividend Yield
Not covered
52W Position
66%
Beta
2.02

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.99
P/S
14.04
EV/Revenue
11.80
ROE
-41.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 66%
$1.69$5.17

Latest Financials

2025-12-31 FY
Revenue
$35.95M
Net Income
-$104.99M
Total Assets
$359.07M
Free Cash Flow
-$99.30M

Recent news